MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1055/s-0043-1763490

Медицинская библиотека · Arquivos de neuro-psiquiatria · 2023

Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic.

Nascimento Henrique, Videira Gonçalo, Duarte Sara, Correia Carlos, Andrade Carlos

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Due to coronavirus disease 2019 (COVID-19) pandemic response measures, the administration of botulinum toxin (BTX) was delayed for many patients during the first lockdown period in Portugal.

OBJECTIVES

To review the impact of postponing BTX treatment on migraine control.

METHODS

This was a retrospective, single-center study. Patients with chronic migraine who had done at least three previous BTX cycles and were considered responders were included. The patients were divided into two groups, one that has had their treatment delayed (group P), and one that has not (controls). The Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) protocol was used. Migraine-related data were obtained at baseline and at three subsequent visits.

RESULTS

The present study included two groups, group P (n = 30; 47.0 ± 14.5 years; 27 females, interval baseline -1st visit: 5.5 [4.1-5.8] months) and the control group (n = 6; 57.7 ± 13.2 years; 6 females; interval baseline-1st visit 3.0 [3.0-3.2] months). No difference between the groups was present at baseline. When compared to baseline, the number of days/month with migraine (5 [3-6.2] vs. 8 [6-15] p < 0.001), days using triptans/month (2.5 [0-6] vs. 3 [0-8], p = 0.027) and intensity of pain (7 [5.8-10] vs. 9 [7-10], p = 0.012) were greater in the first visit for group P, while controls did not present a significant variation. The worsening of migraine-related indicators decreased in the following visits; however, even in the third visit, it had not returned to baseline. Correlations were significant between the delayed time to treatment and the increase in days/month with migraines at the first visit after lockdown (r = 0.507; p = 0.004).

CONCLUSIONS

There was a deterioration of migraine control after postponed treatments, with a direct correlation between the worsening of symptoms and the number of months that the treatment was delayed.

Для цитирования: Nascimento Henrique, Videira Gonçalo, Duarte Sara, Correia Carlos, Andrade Carlos. Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic.. Arquivos de neuro-psiquiatria. 2023. DOI: 10.1055/s-0043-1763490.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.